Full-Time
Staff Software Engineer
Osmind
51-200 employees
Mental health EMR platform with billing
Compensation Overview
$200k - $240k/yr
Remote in USA
Remote
 Software Engineering (1) |
|---|
- 8+ years of full-stack engineering experience, at least 4 years at the Senior level, shipping complex features in production systems
- Demonstrated track record leading technical initiatives that span multiple teams or systems
- Extensive experience with 0-1 builds
- Proficient with AI coding tools as part of daily development
- Experience at early-staged venture-backed startups (e.g. seed through Series C stage)
- Strong communicator who can align stakeholders around technical decisions
- Passion for improving mental healthcare
- Own and drive architecture decisions across our stack, setting patterns the whole team builds on
- Lead complex, ambiguous product challenges end-to-end—from technical design through shipping to end users
- Mentor other engineers through code reviews, design feedback, and pairing
- Partner with Product, Design, and Clinical teams to translate clinical workflows into scalable solutions
- Identify and drive improvements to technical debt, reliability, and developer experience
- Champion AI tools in your daily workflow and help establish team-wide best practices
- HIPAA-regulated healthcare or fintech experience
- AI/ML integration in production
- Based in San Francisco and able to go into the office 2 days per week
Osmind provides an EMR platform tailored for mental health professionals, including psychiatrists and therapists. It combines billing, scheduling, patient engagement, intake forms, and automated outcome measures in one easy-to-use system. The service is offered on a subscription basis, plus a flat-rate patient payment option with no per-transaction fees to streamline workflows. Its goal is to help clinicians deliver care more efficiently and increase patient access to innovative treatments.
Company Size
51-200
Company Stage
Series B
Total Funding
$57.1M
Headquarters
San Francisco, California
Founded
2020
Simplify's Take
What believers are saying
- Compass Pathways collaboration prepares clinics for FDA-approved psychedelics.
- CareNet GPO partnership delivers SPRAVATO savings to 1,000+ practices.
- Cybin partnership accelerates commercial rollout using Osmind's data platform.
What critics are saying
- Epic's Canto module captures 60% psychiatry EHR market within 24 months.
- Headspace acquires Power, eroding Osmind's share in 6-12 months.
- FDA denies COMP360 approval, wasting Osmind's psychedelic R&D investments.
What makes Osmind unique
- Osmind's EHR tailors workflows for ketamine, Spravato, TMS, and psychedelic therapies.
- Osmind aggregates two million patient outcomes for real-world ketamine analyses.
- Osmind networks over 1,000 independent interventional psychiatry practices nationwide.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Osmind who can refer or advise you
Benefits
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↓ -4%2 year growth
↓ -4%Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced a strategic partnership with Osmind, a leading service provider advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need.
Osmind announces collaboration with the American Psychiatric Association to advance quality psychiatric care and accelerate research.
SAN FRANCISCO--(BUSINESS WIRE)--Today, Osmind, the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry. This collaboration between Osmind and APA’s PsychPRO registry intends to broaden access to personalized care, improve patient outcomes, generate robust real-world evidence (RWE) and accelerate psychiatry’s evolution to precision medicine. PsychPRO registry is a clinical data registry that enables the collection and analysis of clinical data to advance quality improvement efforts and accelerate research for the psychiatric community. "At Osmind, we emphasize the importance of clinicians participating in evidence-generating medicine to help shape the future of mental health care, especially as the psychiatric field begins to embrace new treatments and precision psychiatry,” said Carlene MacMillan, MD, Chief Medical Officer of Osmind. “Clinicians in private practice juggle many competing demands so it is crucial we make participation both easy and worthwhile to them.". Osmind is integrating a number of APA’s diagnostic and outcomes measures of interest, including the DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure developed by APA researchers, into its electronic health record (EHR) software
Starting today, mental health clinicians, practice owners, and researchers have free access to sessions led by the nation's foremost mental health clinicians driving breakthrough medicineSAN FRANCISCO, Dec. 5, 2023 /PRNewswire-PRWeb/ -- Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced its inaugural Breakthrough Mental Health Treatment Forum is now open to virtual attendees. Sessions will focus on mental health treatment research, how to build a successful practice, and the value of community in delivering care. The forum brings together psychiatrists, nurse practitioners, psychotherapists, scientists, clinicians, mental health practice leaders and administrators, and academics all dedicated to advancing therapeutic options for people facing severe and treatment-resistant mental illness."The mental health crisis continues to grow, yet critical advancements in psychiatric treatment are lagging behind," said Lucia Huang, co-founder and CEO of Osmind. "This forum is a unique space for those on the leading edge of novel therapeutic care to hear from leaders driving future innovations on the frontlines of breakthrough mental health care, helping more patients access effective care, and supporting future collaborations."The three-day forum will run from Tuesday, December 5 through Thursday, December 7. Content is available asynchronously
Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced Osmind Claims, which introduces new billing capabilities purpose-built to simplify insurance reimbursement for psychiatric treatment, enabling greater access to insurance-supported mental health care.